Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
Launched by DESMOND TUTU HIV FOUNDATION · Oct 27, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific message, known as U=U (Undetectable = Untransmittable), can improve HIV care for men in South Africa. The U=U message means that men living with HIV who take their medication and achieve an undetectable viral load (which means the virus is so low it can't be passed on to others) can’t sexually transmit the virus. The study aims to see if this message helps more men get tested for HIV, start treatment, stay engaged in their care, and ultimately achieve better health outcomes.
To be eligible for the study, participants need to be male, at least 15 years old, and either new to treatment or returning after having missed care for six months. Participants will receive counseling and support related to the U=U message, and researchers will gather information on how well these efforts work. The trial is currently looking for volunteers in Buffalo City and Cape Town. If you join, you can expect to receive helpful information about HIV care and support, and your involvement will contribute to important research that could improve health services for men living with HIV in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- AIM 1:
- • 1. male
- • 2. aged ≥15 years
- • 3. present a study issued invitation card to site receptionist
- • 4. ability to provide informed consent.
- AIM 2:
- • 1. cis-gender men
- • 2. aged ≥15 years
- • 3. newly initiating ART (i.e., treatment naïve) or re-initiating ART after 6 months of being lost-to-care
- • 4. live in Buffalo City or Cape Town Metro Health Districts
- • 5. provide written informed consent
About Desmond Tutu Hiv Foundation
The Desmond Tutu HIV Foundation is a prominent clinical research organization dedicated to advancing the understanding and treatment of HIV/AIDS. Founded in honor of the legacy of Archbishop Desmond Tutu, the foundation focuses on innovative research, community engagement, and capacity building in the field of HIV prevention and care. With a commitment to improving health outcomes, the foundation conducts clinical trials and collaborates with local and international partners to implement evidence-based interventions, enhance healthcare access, and empower underserved communities in the fight against HIV. Through its comprehensive approach, the Desmond Tutu HIV Foundation aims to contribute significantly to global efforts in combating the epidemic and promoting health equity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
East London, Eastern Cape, South Africa
Cape Town, Western Cape, South Africa
Patients applied
Trial Officials
Andrew Medina-Marino, PhD
Principal Investigator
Desmond Tutu Health Foundation
Alison Buttenheim, PhD, MBA
Principal Investigator
Penn Nursing and Perelman School of Medicine, University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials